HAVCR2 and type 2 diabetes mellitus: (a) Flow cytometry analysis of Tim‐3 expression on CD14+ monocytes cells (left) and the statistical graph is shown (right) for type 2 diabetes patients (n = 31, 30.43 ± 3.58%) and healthy donors (n = 18, 50.78 ± 2.36%).